UNITY Biotechnology Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$210.6M
Lead Investor(s):EcoR1 Capital Fund, 6 Dimensions Capital

Estimated Revenue & Financials

  • UNITY Biotechnology's estimated annual revenue is currently $10.9M per year.(?)
  • UNITY Biotechnology received $55.0M in venture funding in March 2018.
  • UNITY Biotechnology's estimated revenue per employee is $155,000
  • UNITY Biotechnology's total funding is $210.6M.

Employee Data

  • UNITY Biotechnology has 70 Employees.(?)
  • UNITY Biotechnology grew their employee count by -26% last year.
  • UNITY Biotechnology currently has 1 job openings.

UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com.